Literature DB >> 11818483

The mechanisms of action of PPARs.

Joel Berger1, David E Moller.   

Abstract

The peroxisome proliferator-activated receptors (PPARs) are a group of three nuclear receptor isoforms, PPAR gamma, PPAR alpha, and PPAR delta, encoded by different genes. PPARs are ligand-regulated transcription factors that control gene expression by binding to specific response elements (PPREs) within promoters. PPARs bind as heterodimers with a retinoid X receptor and, upon binding agonist, interact with cofactors such that the rate of transcription initiation is increased. The PPARs play a critical physiological role as lipid sensors and regulators of lipid metabolism. Fatty acids and eicosanoids have been identified as natural ligands for the PPARs. More potent synthetic PPAR ligands, including the fibrates and thiazolidinediones, have proven effective in the treatment of dyslipidemia and diabetes. Use of such ligands has allowed researchers to unveil many potential roles for the PPARs in pathological states including atherosclerosis, inflammation, cancer, infertility, and demyelination. Here, we present the current state of knowledge regarding the molecular mechanisms of PPAR action and the involvement of the PPARs in the etiology and treatment of several chronic diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818483     DOI: 10.1146/annurev.med.53.082901.104018

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  689 in total

1.  Peroxisome proliferator-activated receptor gamma gene polymorphisms and restenosis in diabetic patients after stenting in coronary arteries.

Authors:  W Koch; V Jung; N von Beckerath; A Schömig; A Kastrati
Journal:  Diabetologia       Date:  2004-05-20       Impact factor: 10.122

Review 2.  Crosstalk of oncogenic and prostanoid signaling pathways.

Authors:  Rolf Müller
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

Review 3.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 4.  The health promoting properties of the conjugated isomers of α-linolenic acid.

Authors:  Alan A Hennessy; R Paul Ross; Rosaleen Devery; Catherine Stanton
Journal:  Lipids       Date:  2010-12-15       Impact factor: 1.880

5.  Non-hormonal mediators of uterine fibroid growth.

Authors:  Esra Cetin; Ayman Al-Hendy; Michał Ciebiera
Journal:  Curr Opin Obstet Gynecol       Date:  2020-10       Impact factor: 1.927

6.  PPARγ Agonists Attenuate Trigeminal Neuropathic Pain.

Authors:  Danielle N Lyons; Liping Zhang; Robert J Danaher; Craig S Miller; Karin N Westlund
Journal:  Clin J Pain       Date:  2017-12       Impact factor: 3.442

7.  18β-Glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation.

Authors:  Ayman M Mahmoud; Hussein S Al Dera
Journal:  Genes Nutr       Date:  2015-09-19       Impact factor: 5.523

8.  Peroxisome proliferator-activated receptor gamma controls Muc1 transcription in trophoblasts.

Authors:  Tali Shalom-Barak; Jill M Nicholas; Yongxu Wang; Xiaowen Zhang; Estelita S Ong; Timothy H Young; Sandra J Gendler; Ronald M Evans; Yaacov Barak
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.

Authors:  Ying Wang; Wenwen Lin; Jianghua Ju
Journal:  Cell Cycle       Date:  2020-04-15       Impact factor: 4.534

10.  Fibrate treatment of eEOCs in murine AKI.

Authors:  Daniel Patschan; Katrin Schwarze; Elvira Henze; Susann Patschan; Roman Scheidemann; Gerhard Anton Müller
Journal:  J Nephrol       Date:  2014-01-16       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.